- A new study in the New England Journal of Medicine found the bivalent Omicron booster triggered a strong antibody response against the Omicron variant after 28 days.
- Current research suggests the side effects of the new bivalent Omicron booster shot can include pain, fatigue, headache, muscle pain, chills, joint pain, swelling and redness at the injection site, and fever.
- The CDC stated the new bivalent Omicron boosters are expected to be available in early to mid-October for children ages 5 through 11.
- HHS announced that several million bivalent Omicron boosters will be sent to retail pharmacies for distribution.
White House and Federal Agencies
- The CDC stated the new bivalent Omicron boosters are expected to be available in early to mid-October for children ages 5 through 11.
- The Biden Administration mandate, requiring Head Start child care facility staff to be vaccinated and wear masks, was struck down by U.S. District Judge Terry A. Doughty.
- HHS announced that several million bivalent Omicron boosters will be sent to retail pharmacies for distribution.
Vaccine, Testing, and Treatment
- Pharmacies and hospitals in Hawaii, California, and Washington D.C. reported shortages of the newly authorized Moderna bivalent Omicron booster shot.
- Current research suggests the side effects of the new bivalent Omicron booster shot can include pain, fatigue, headache, muscle pain, chills, joint pain, swelling and redness at the injection site, and fever.
- A new study in the New England Journal of Medicine found the bivalent Omicron booster triggered a strong antibody response against the Omicron variant after 28 days.
- The American Academy of Pediatrics reported only 27% of children between the ages of 5 through 11 have been fully vaccinated.
- A new study in the Journal of the American Medical Association found around 20% of individuals who have been infected with COVID-19 reported long COVID symptoms.
- Researchers anticipate more than one subvariant of Omicron, including subvariant BA.2.75.2, to appear during the fall season.
Centers for Disease Control and Prevention (CDC) Updates
The CDC published the following reports and website updates:
- Cases in the U.S.
- Risk for COVID-19 Infection, Hospitalization, and Death By Age Group
- Risk for COVID-19 Infection, Hospitalization, and Death By Race/Ethnicity
- Mortality Risk Among Patients Hospitalized Primarily for COVID-19 During the Omicron and Delta Variant Pandemic Periods — United States, April 2020–June 2022
- COVID Data Tracker Weekly Review
- Selected Adverse Events Reported after COVID-19 Vaccination
